launch of the Diphtheria routine immunization campaign in Igabi LGA, Kaduna state
In anticipation of tomorrow’s launch of the Diphtheria routine immunization campaign in Igabi LGA, Kaduna state on February 29, 2024, the e-CAPH team executed a strategic advocacy and sensitization mission to Rigasa district. Spearheaded by the Social Mobilization Officer, Local Government Immunization Officer, UNICEF consultant, and Afenet, the team engaged the district head and council members, including various village heads.
During this impactful meeting, the district head issued directives to all council members, urging them to proactively mobilize their communities for the upcoming campaign. This collaborative effort has set the stage for a well-coordinated approach to achieving our immunization goals and, ultimately, safeguarding community health.
e-CAPH is committed to routine immunization, and this commitment extends beyond mere rhetoric. Our team’s proactive involvement in advocacy and awareness activities underscores our dedication to ensuring vaccine acceptance within the community. By fostering partnerships with local leaders and leveraging the expertise of UNICEF and Afenet, we aim to create a robust support system that transcends administrative boundaries.
The success of tomorrow’s Diphtheria routine immunization kickoff hinges on our collective efforts in building awareness and acceptance. Through strategic advocacy, we seek to empower communities with knowledge, dispel myths, and instill confidence in the importance of routine immunization. Our commitment to this cause is unwavering, driven by a shared vision of a healthier and more resilient community.
As e-CAPH takes a leading role in this endeavor, we invite everyone to join hands in championing routine immunization. Together, let us bridge the gap between awareness and action, ensuring that every individual in Igabi LGA receives the protection they deserve. Your support is integral to our mission, and through united efforts, we can build a healthier, more resilient future for all.
Comment (1)
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam viverra euismod odio, gravida pellentesque urna varius vitae, gravida pellentesque urna varius vitae.